Seeking a More Trustworthy Global Supply Chain
This article was originally published in The Gold Sheet
Restoring trust: Now that suspect ingredients from China have infiltrated legitimate supply chains for glycerin, pet food and heparin, drug makers are asking what more they must do to remain confident in the integrity of their own supply chains. FDA urges them to audit more suppliers more thoroughly, while APIC's Oldenhof calls for testing and auditing API makers to build 'justified trust' and gives some tips on what to look for. Some technology approaches draw favor, such as fingerprinting facilities by examining their products. Third-party solutions to auditing excipient and API makers are promoted, though uptake has been slow.
You may also be interested in...
PCCA repackaged adulterated APIs, Allay failed to understand processes, ShangRao and Mexican firms peddled subpotent, sometimes methanol-tainted ethanol.
Two batches were authorized because they were made before production waste jammed Emergent BioSolutions' Bayview plant.
Selective whistleblower allegations, investigative reports hint at drug GMP issues awaiting US FDA inspection resumption; GSK sotrovimab EUA gets root cause provision; API GMP compliance work acknowledged; Aziyo recalls bone matrix associated with tuberculosis outbreak, and other matters in this latest update.